David Boocock Selected Research

Anthocyanins (Anthocyanin)

11/2006

Effect of cyanidin-3-glucoside and an anthocyanin mixture from bilberry on adenoma development in the ApcMin mouse model of intestinal carcinogenesis--relationship with tissue anthocyanin levels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Boocock Research Topics

Disease

2	Neoplasms (Cancer) 01/2021 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 11/2006 - 05/2006
1	Experimental Melanoma 01/2021
1	Neuroblastoma 11/2020
1	Fibrosis (Cirrhosis) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Tongue Neoplasms (Tongue Neoplasm) 01/2018
1	Lymphatic Metastasis 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2012
1	Cognitive Dysfunction 01/2012
1	Carcinogenesis 11/2006
1	Adenoma (Adenomas) 11/2006
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 11/2006
1	Intestinal Neoplasms (Intestinal Cancer) 05/2006
1	Adenocarcinoma 05/2006

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2012
1	VaccinesIBA 01/2021
1	Cancer VaccinesIBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	homocitrullineIBA 01/2021
1	InterferonsIBA 01/2021
1	CyanatesIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	phenylsaligenin cyclic phosphate (PSCP)IBA 11/2020
1	O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphateIBA 11/2020
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	polydatinIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	cyanidin-3-O-beta-glucopyranosideIBA 11/2006
1	Anthocyanins (Anthocyanin)IBA 11/2006
1	CarcinogensIBA 11/2006
1	FlavonoidsIBA 11/2006
1	Phosphatidylcholines (Phosphatidylcholine)IBA 05/2006
1	Silybin (Lagosa)IBA 05/2006
1	IdB 1016IBA 05/2006

Therapy/Procedure

1	Therapeutics 01/2021
1	Immunotherapy 01/2021